Online PCT Training for Clinicians

临床医生在线 PCT 培训

基本信息

  • 批准号:
    7912669
  • 负责人:
  • 金额:
    $ 70.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-04-01 至 2012-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Panic attacks (PA) impact about 23% of adults in community samples. Panic disorder with or without agoraphobia (PDA) tends to be a chronic condition with a lifetime prevalence of 4.7%. When untreated, panic disorder (PD) often leads to debilitating problems, with severe financial and interpersonal costs. Panic Control Treatment (PCT) is an efficacious treatment for PD. The overarching goal of this project is to facilitate the dissemination of PCT (aka MAP; Mastery of Your Anxiety and Panic) to clinicians who treat PD by creating the Online PCT Training for Clinicians (PCT OLT). In Phase I, we produced an innovative OLT prototype comprised of 143 screens using an iterative process of development with feedback from target end-users and PCT experts. A randomized controlled trial (RCT; N=31) was then conducted comparing the PCT OLT to a control OLT. PCT OLT subjects significantly outperformed controls on all outcome variables, including knowledge, recall, and self-efficacy. Results were maintained at the one week follow up. The proposed Phase II project extends this work by expanding the OLT and its evaluation in Phase II. Specifically, we will include all remaining content from the PCT manuals and add additional clinical scenarios and performance-based interactivities. We will test the program's efficacy in a RCT (N=180) using an additive research design of three training approaches: text (n=60), text + PCT OLT (PCT OLT; n=60), vs. text + PCT OLT + expert weekly consultation (Hybrid; n= 60). Outcome variables will again include PCT knowledge, as well as self-efficacy in treating PDA clients with PCT. We will expand the assessments to include a computer- generated clinical application test of competence and fidelity to PCT and course completion. Subjects will be assessed pre- and post-training, then again at 30-day and 60-day post-training follow-ups. PUBLIC HEALTH RELEVANCE: Although empirically-based treatments do exist for people diagnosed with panic disorder (PD), only a relatively small percentage of this population will receive such treatments. Panic Control Treatment (aka Mastery of Anxiety and Panic; MAP) is an efficacious treatment for PD. The intent of this project is to develop a uniquely comprehensive and interactive online training in MAP, to aid in the dissemination of this evidence based treatment, in order to improve clinical outcomes for patients suffering from PD.
描述(由申请人提供):惊恐发作(PA)影响社区样本中约23%的成年人。惊恐障碍伴或不伴广场恐怖症(PDA)往往是一种慢性疾病,终生患病率为4.7%。如果不治疗,惊恐障碍(PD)往往会导致衰弱的问题,严重的经济和人际关系的成本。惊恐控制治疗(PCT)是PD的有效治疗方法。该项目的总体目标是通过创建临床医生在线PCT培训(PCT奥尔特),促进PCT(又名MAP;掌握您的焦虑和恐慌)向治疗PD的临床医生的传播。在第一阶段,我们根据目标最终用户和PCT专家的反馈,采用迭代开发流程,生产了一个由143个屏幕组成的创新奥尔特原型。然后进行随机对照试验(RCT; N=31),比较PCT奥尔特与对照奥尔特。PCT奥尔特受试者在所有结局变量(包括知识、回忆和自我效能)上均显著优于对照组。结果在一周随访时保持不变。拟议的第二阶段项目通过扩大奥尔特及其在第二阶段的评估来扩展这项工作。具体而言,我们将纳入PCT手册中的所有剩余内容,并添加其他临床场景和基于性能的交互。我们将在一项随机对照试验(N=180)中使用三种训练方法的加法研究设计来测试该计划的有效性:文本(n=60),文本+ PCT奥尔特(PCT奥尔特; n=60),与文本+ PCT奥尔特+专家每周咨询(混合; n= 60)。结果变量将再次包括PCT知识,以及在治疗PDA客户与PCT的自我效能。我们将扩大评估范围,包括计算机生成的临床应用测试,以测试PCT的能力和忠诚度以及课程完成情况。将在培训前和培训后对受试者进行评估,然后在培训后30天和60天随访时再次进行评估。 公共卫生相关性:虽然对被诊断患有惊恐障碍(PD)的人确实存在基于药物的治疗,但只有相对较小比例的这类人群会接受这种治疗。惊恐控制治疗(又名焦虑和惊恐的掌握; MAP)是PD的有效治疗方法。该项目的目的是开发一个独特的全面和互动的MAP在线培训,以帮助传播这种循证治疗,以改善PD患者的临床结局。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David H. Barlow其他文献

Is Prolonged Grief Disorder an Emotional Disorder?
长期悲伤障碍是情绪障碍吗?
  • DOI:
    10.1080/15325024.2023.2236931
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    4.7
  • 作者:
    Daniella Spencer;Andrew J. Curreri;Brittany A. Jaso;Nicole D. Cardona;Elizabeth H. Eustis;David H. Barlow;T. Farchione
  • 通讯作者:
    T. Farchione
Structure of anxiety and the anxiety disorders: a hierarchical model.
焦虑和焦虑症的结构:分层模型。
  • DOI:
    10.1037/0021-843x.105.2.181
  • 发表时间:
    1996
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    R. Zinbarg;David H. Barlow
  • 通讯作者:
    David H. Barlow
The unified protocol for transdiagnostic treatment of emotional disorders:Client workbook
情绪障碍跨诊断治疗的统一方案:客户工作手册
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    David H. Barlow;K. Ellard;C. Fairholme;CP Farchione;Christina L. Boisseau;Laura B. Allen;Jill Ehrenreich
  • 通讯作者:
    Jill Ehrenreich
Discriminating between generalized anxiety disorder and anxiety disorder not otherwise specified in a Hispanic population: Is it only a matter of worry?
区分广泛性焦虑症和西班牙裔人群中未特指的焦虑症:这只是担心的问题吗?
  • DOI:
  • 发表时间:
    1997
  • 期刊:
  • 影响因子:
    7.4
  • 作者:
    L. Street;E. Salmán;Robin Garfinkle;Joao Silvestri;José L. Carrasco;D. Cárdenas;R. Zinbarg;David H. Barlow;M. Liebowitz
  • 通讯作者:
    M. Liebowitz
An experimental analysis of classical conditioning as a method of increasing heterosexual arousal in homosexuals
  • DOI:
    10.1016/s0005-7894(74)80084-5
  • 发表时间:
    1974-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Steven H. Herman;David H. Barlow;W. Stewart Agras
  • 通讯作者:
    W. Stewart Agras

David H. Barlow的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David H. Barlow', 18)}}的其他基金

Efficacy Evaluation of Transdiagnostic CBT for Comorbid Alcohol Use and Anxiety Disorder
跨诊断 CBT 对共病酒精使用和焦虑症的疗效评估
  • 批准号:
    9263535
  • 财政年份:
    2017
  • 资助金额:
    $ 70.54万
  • 项目类别:
Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety Disorders
焦虑症统一跨诊断治疗的疗效评估
  • 批准号:
    8040318
  • 财政年份:
    2010
  • 资助金额:
    $ 70.54万
  • 项目类别:
Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety Disorders
焦虑症统一跨诊断治疗的疗效评估
  • 批准号:
    8391726
  • 财政年份:
    2010
  • 资助金额:
    $ 70.54万
  • 项目类别:
Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety Disorders
焦虑症统一跨诊断治疗的疗效评估
  • 批准号:
    8589008
  • 财政年份:
    2010
  • 资助金额:
    $ 70.54万
  • 项目类别:
Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety Disorders
焦虑症统一跨诊断治疗的疗效评估
  • 批准号:
    8207886
  • 财政年份:
    2010
  • 资助金额:
    $ 70.54万
  • 项目类别:
Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety Disorders
焦虑症统一跨诊断治疗的疗效评估
  • 批准号:
    8538551
  • 财政年份:
    2010
  • 资助金额:
    $ 70.54万
  • 项目类别:
Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism
两种新型抗惊厥药治疗酒精中毒的跨学科研究
  • 批准号:
    9353265
  • 财政年份:
    2009
  • 资助金额:
    $ 70.54万
  • 项目类别:
Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism
两种新型抗惊厥药治疗酒精中毒的跨学科研究
  • 批准号:
    8990076
  • 财政年份:
    2009
  • 资助金额:
    $ 70.54万
  • 项目类别:
Online PCT Training for Clinicians
临床医生在线 PCT 培训
  • 批准号:
    7394696
  • 财政年份:
    2008
  • 资助金额:
    $ 70.54万
  • 项目类别:
Online PCT Training for Clinicians
临床医生在线 PCT 培训
  • 批准号:
    8123323
  • 财政年份:
    2008
  • 资助金额:
    $ 70.54万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.54万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 70.54万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 70.54万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 70.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 70.54万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 70.54万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 70.54万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 70.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 70.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 70.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了